Cell-Specific Delivery of Polymeric Nanoparticles to Carbohydrate-Tagging Cells
Authors:
- Yasuhiko IwasakiYIYasuhiko Iwasaki
- Haruki MaieHMHaruki Maie
- Kazunari AkiyoshiKAKazunari Akiyoshi
- 21 September 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 8 (10) , 3162-3168
Abstract
Carbohydrates on cell surfaces contribute a variety of communications between the cell and its environment, and they have been assumed to act as markers for cellular recognition. In this research, 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer nanoparticles, which can react with specific carbohydrates of target cells, were newly prepared to serve as novel drug carriers. A water-soluble MPC polymer bearing hydrazide groups (PMBH) was synthesized by conventional radical polymerization. The MPC polymer showed amphiphilic nature and worked as an emulsifier to form nanoparticles. The nanoparticles covered with PMBH were prepared by the solvent evaporation method and exhibited monodispersity. They were approximately 200 nm in diameter and −2.0 mV in surface potential. According to a surface analysis of the nanoparticles, phosphorylcholine and hydrazide groups were observed, and the surface was fully covered with PMBH. Unnatural carbohydrates having ketone groups on human cervical carcinoma cell (HeLa) surfaces were expressed by treatment with levulinoyl mannosamine (ManLev). When the PMBH nanoparticles were in contact with the ManLev-treated HeLa cells, they accumulated in the cells. In contrast, the nanoparticles were not observed in native HeLa cells (without unnatural carbohydrates). These results indicate that the hydrazide groups of the nanoparticles selectively reacted to the ketone groups of the carbohydrates on the cell surface. The PMBH nanoparticles immobilized with anticancer drugs such as doxorubicin or paclitaxel were in contact with either ManLev-treated or untreated HeLa cells. The viability of the ManLev-treated HeLa cells was effectively reduced, but that of the untreated cells was preserved. This indicated that the anticancer drugs were selectively delivered to the ManLev-treated cells. Nonspecific cellular uptake of the nanoparticles was effectively reduced by MPC polymer coating. Furthermore, the immobilization processes of the drugs differed because of the solubility of the drugs. In conclusion, cellular-specific drug delivery by means of the novel nanoparticles was demonstrated with the selective reaction between unnatural carbohydrates on the cell surface and the hydrazide groups bearing the phosphorylcholine polymer nanoparticles.Keywords
This publication has 34 references indexed in Scilit:
- Nonfouling Characteristics of Dextran-Containing SurfacesLangmuir, 2006
- Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian CellsNano Letters, 2006
- Physico-chemical characterization of polysaccharide-coated nanoparticlesJournal of Controlled Release, 2005
- Selective Cell Attachment to a Biomimetic Polymer Surface through the Recognition of Cell-Surface TagsBioconjugate Chemistry, 2005
- Chemical remodelling of cell surfaces in living animalsNature, 2004
- The endocytic pathway: a mosaic of domainsNature Reviews Molecular Cell Biology, 2001
- Cell Surface Engineering by a Modified Staudinger ReactionScience, 2000
- Why do phospholipid polymers reduce protein adsorption?Journal of Biomedical Materials Research, 1998
- Is Cremophor EL, solvent for paclitaxel, cytotoxic?The Lancet, 1993
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992